Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Divis's Labs stock hits a 52-week low following USFDA import alert on key unit

Shares of Divi's Laboratories hit a 52-week low of Rs 635 on Tuesday after the company informed BSE that USFDA had issued them an import alert on 20th March, for the products manufactured at their unit at Visakhapatnam, Andhra Pradesh.